CRL - Charles River Laboratories - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRL is currently covered by 10 analysts with an average price target of $227.9. This is a potential upside of $31.02 (-19.09%) from yesterday's end of day stock price of $281.67.

Charles River Laboratories's activity chart (see below) currently has 218 price targets and 163 ratings on display. The stock rating distribution of CRL is 48.28% HOLD and 51.72% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.9% with an average time for these price targets to be met of 143.24 days.

Highest price target for CRL is $320, Lowest price target is $160, average price target is $227.9.

Most recent stock forecast was given by ROSS MUKEN from EVERCORE on 10-Sep-2026. First documented stock forecast 13-Mar-2014.

Currently out of the existing stock ratings of CRL, 14 are a HOLD (48.28%), 15 are a BUY (51.72%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Apr-2019

$320

$41.74 (15.00%)

$300

7 days ago
(10-Sep-2026)

5/7 (71.43%)

$41.74 (15.00%)

140

Buy Since 12-Oct-2025

$300

$21.74 (7.81%)

$235

1 months 8 days ago
(09-Aug-2026)

12/13 (92.31%)

$23 (8.30%)

188

Hold Since 02-Feb-2025

$310

$31.74 (11.41%)

$160

1 months 12 days ago
(05-Aug-2026)

6/7 (85.71%)

$44.49 (16.76%)

25

Hold Since 06-Jun-2024

$230

$-48.26 (-17.34%)

$175

2 months 5 days ago
(12-Jul-2026)

9/9 (100%)

$0.25 (0.11%)

36

Hold Since 04-Aug-2022

$220

$4.25 (1.97%)

$168

3 months ago
(17-Jun-2026)

10/11 (90.91%)

$37.66 (20.65%)

159

Show more analysts

Please expand the browser size to see the chart

What is CRL (Charles River Laboratories) average time for price targets to be met?

On average it took 143 days for the stock forecasts to be reached, with an average price target met ratio of 80.9%.

Which analyst most recently updated their price target on CRL (Charles River Laboratories)?

Ross Muken

Which analyst has the most public recommendations on CRL (Charles River Laboratories)?

Ross Muken works at EVERCORE and has 0 price targets and 2 ratings on CRL

Which analyst is the currently most bullish on CRL (Charles River Laboratories)?

Robert Jones with the highest potential upside of $153.35

Which analyst is the currently most reserved on CRL (Charles River Laboratories)?

Elizabeth Anderson with the lowest potential downside of -$108.26

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?